To confirm that reduced PLEKHA7 expression contributes to gastric tumour progression, we performed a range of biochemical and pathological statistical analyses, and the results showed that patients with lower PLEKHA7 expression exhibited lower overall survival. Here, PLEKHA7 is linked to gastric neoplasm.